REASSESSMENT OF BENEFIT RISK RATIO AND TREATMENT ALGORITHMS FOR ANTIARRHYTHMIC DRUG-THERAPY AFTER THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL

被引：17
作者：
ANDERSON, JL [1 ]
机构：
[1] UNIV UTAH, SCH MED, DIV CARDIOL, SALT LAKE CITY, UT 84112 USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1990年 / 30卷 / 11期
关键词：
D O I：
10.1002/j.1552-4604.1990.tb03582.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：981 / 989
页数：9
相关论文
共 47 条
[11]  
[Anonymous], 1989, NEW ENGL J MED, V321, P406
[12]  
[Anonymous], 1988, AM J CARDIOL, V61, P501
[13]   DEFINITION OF BENIGN VERSUS MALIGNANT VENTRICULAR ARRHYTHMIAS - TARGETS FOR TREATMENT [J].
BIGGER, JT .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 52 (06) :C47-C54
[14]  
CHAMBERLAIN DA, 1980, LANCET, V2, P1324
[15]   FLECAINIDE-INDUCED VENTRICULAR-TACHYCARDIA AND FIBRILLATION IN PATIENTS TREATED FOR ATRIAL-FIBRILLATION [J].
FALK, RH .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (02) :107-111
[16]   EFFECT OF ANTI-ARRHYTHMIC DRUGS ON MORTALITY AFTER MYOCARDIAL-INFARCTION [J].
FURBERG, CD .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 52 (06) :C32-C36
[17]   EFFECTS OF TIMOLOL AND PROPRANOLOL ON INDUCIBLE SUSTAINED VENTRICULAR TACHYARRHYTHMIAS IN DOGS WITH SUBACUTE MYOCARDIAL-INFARCTION [J].
GANG, ES ;
BIGGER, JT ;
UHL, EW .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (02) :275-281
[18]  
GOMES JA, 1987, J AM COLL CARDIOL, V10, P349
[19]   PROPHYLACTIC ANTIARRHYTHMIC THERAPY OF HIGH-RISK SURVIVORS OF MYOCARDIAL-INFARCTION - LOWER MORTALITY AT 1 MONTH BUT NOT AT 1 YEAR [J].
GOTTLIEB, SH ;
ACHUFF, SC ;
MELLITS, ED ;
GERSTENBLITH, G ;
BAUGHMAN, KL ;
BECKER, L ;
CHANDRA, NC ;
HENLEY, S ;
HUMPHRIES, JO ;
HECK, C ;
KENNEDY, MM ;
WEISFELDT, ML ;
REID, PR .
CIRCULATION, 1987, 75 (04) :792-799
[20]   A SYMPOSIUM - ENCAINIDE - INTRODUCTION [J].
HARRISON, DC ;
MORGANROTH, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 58 (05) :C1-C3
12345